| Literature DB >> 29132400 |
María Fernanda Álvarez Barreneche1, Carlos Andrés Restrepo Castro2,3, Alicia Hidrón Botero2,4,5, Juan Pablo Villa Franco2, Ivan Mauricio Trompa Romero3, Laura Restrepo Carvajal2, Alejandro Eusse García2, Adriana Ocampo Mesa6, Lina María Echeverri Toro6,7, Glenys Patricia Porras Fernández de Castro8, Jaime Mauricio Ramírez Rivera6,7, Carlos Andrés Agudelo Restrepo2,6,9.
Abstract
BACKGROUND: Antiretroviral therapy (ART) has modified the natural history of HIV-infection: the incidence of opportunistic infections (OIs) has decreased and mortality associated to HIV has improved dramatically. The reasons for hospitalization have changed; OIs are no longer the most common reason for admission. This study describes the patient population, admission diagnosis and hospital course of HIV patients in Colombia in the ART era.Entities:
Keywords: Acquired immune deficiency syndrome; Adherence; Antiretroviral; Hospitalization; Human immunodeficiency virus; Opportunistic infections
Mesh:
Year: 2017 PMID: 29132400 PMCID: PMC5683524 DOI: 10.1186/s12981-017-0186-3
Source DB: PubMed Journal: AIDS Res Ther ISSN: 1742-6405 Impact factor: 2.250
Fig. 1HIV patients hospitalized in Medellín, Colombia from August 2014 to July 2015
Baseline characteristics for 551 patients with HIV infection admitted to medical ward
| Patient characteristics | All patients, n = 551 | Previous HIV diagnosis, n = 430 | AIDS-defining illness, n = 301 |
|---|---|---|---|
| Age, median (IQR) | 37 (30–49) | 36 (30–48) | 37 (30–50) |
| Male | 418 (76) | 321 (74.6) | 231 (76.7) |
| Low income | 372 (67.5) | 289 (67.2) | 225 (74.7) |
| Lower educational attainment | 390 (70.8) | 188 (43.7) | 154 (51.1) |
| New HIV diagnosis | 121 (22) | – | 88 (29.2) |
| ART status | |||
| Receiving ART prior to admission | 273 (49.5) | 273 (63.4) | 131 (43.5) |
| Not on ART | 278 (50.4) | 64 (14.9) | 111 (36.8) |
| Abandonment of ART | – | 93 (21.6) | 59 (19.6) |
| Adherence to ARTa | – | 199/366 (54.4) | 83/190 (43.6) |
| Attending HIV program | – | 258 (60.0) | 86 (28.5) |
| Attending HIV program and receiving ART | – | 226/258 (87.6) | 72(23.9) |
| CD4 cell count, cells/μl | 98 (36.2–98) | 117 (41–310) | 59 (24–131) |
| HIV viral load, copies/mL | 100.278 (1.505–384.250) | 36.381 (77–216.441) | 179.000 (26.597–622.022) |
| Anemiab | 104 (18.9) | 90 (20.9) | 76 (25.2) |
| Past history of TB | 88 (20.4) | 88 (20.4) | 55 (18.2) |
aAdherence to ART is calculated with patients who had abandoned ART or were receiving ART prior to admission
bAnemia was defined using WHO criteria (hemoglobin < 11.0 g/dL for both males and females)
Causes of hospitalization in HIV patients in Medellín, Colombia from August 2014 to July 2015 (N = 551)
| Variable | n (%) |
|---|---|
| AIDS defining illnessa | 301 (54.6) |
| Tuberculosis | 128 (23.3) |
| Extrapulmonary tuberculosis | 84 (15.2) |
| Pulmonary tuberculosis | 44 (8.0) |
| Esophageal candidiasis | 56 (10.1) |
| Toxoplasma encephalitis | 43 (7.8) |
| Disseminated histoplasmosis | 39 (7.1) |
| CMV infection | 36 (6.5) |
| Extrapulmonary cryptococcosis | 32 (5.8) |
| Pneumonia by | 32 (5.8) |
| Lymphomab | 27 (4.9) |
| Kaposi’s sarcoma | 11 (2.0) |
| Herpes simplex > 1 month | 10 (1.8) |
| Cryptosporidiosis > 1 month | 10 (1.8) |
| HIV Encephalopathy | 8 (1.4) |
| Wasting syndrome | 7 (1.3) |
| MAC | 4 (0.7) |
| Recurrent salmonellosis | 2 (0.3) |
| Adverse drug effect | 39 (7.1) |
| Non-AIDS-defining illness but related to HIV | 35 (6.2) |
| Another cause of hospitalization not related to HIV | 176 (31.9) |
| Bacterial infection | 61 (11.0) |
| Othersc | 115 (20.9) |
aThe total percentage exceeds 100% because some patients had > 1 defining illness
bBurkitt lymphoma, primary central nervous system lymphoma, immunoblastic lymphoma
cOther: gastrointestinal, neurological, hematological and cardiac alterations, viral infection, pneumopathy, reactive lymphadenopathy
Main findings of HIV patients in Medellín, Colombia from August 2014 to July 2015
| Variable | Patients who died (n = 30) | Patients who survived (n = 521) |
|---|---|---|
| Age | 41.5 | 39.3 |
| Male | 25/30 (83.3) | 393/521 (75.4) |
| Diagnosis during the index admission | 9/30 (30.0) | 112/521 (21.5) |
| Previous HIV diagnosisa | 21/30 (70.0) | 409/521 (78.5) |
| Diagnosis 1–12 months | 6/30 (20.0) | 117/521 (22.5) |
| Diagnosis > 12 months | 15/30 (50.0) | 292/521 (56.0) |
| On antiretroviral therapy at admissionb | 11/21 (52.4) | 262/409 (64.2) |
| Adherencec | 5/18 (27.7) | 194/354 (54.8) |
| CD4 T-cells count < 200 cells/mLd | 28/29 (96.6) | 352/521 (67.4) |
| AIDS-defining illness on admission | 24/30 (80.0) | 277/521 (53.2) |
| Patients with newly diagnosed TB | 7/30 (23.3) | 121/521 (23.2) |
| AIDS defining illness no TB | 17/30 (56.6) | 156/521 (29.9) |
| Two or more OIs | 11/30 (36.6) | 96/521 (18.4) |
| Non-AIDS-defining illness but related to HIV | 2/30 (6.6) | 33/521 (6.3) |
a ≥ 1 month previous to hospitalization
bIn patients diagnosed with HIV before admission
cIn patients who had abandoned ART or were receiving ART prior to admission
dOne patient had no CD4 T-cells count